Blood Group Genotyping for Sickle Cell and Thalassaemi
NHS England Midlands - EastcontractContracts Finder ↗Ref CF-3178200D0O000000rwimUAASME suitableVCSE suitablecomplete
Estimated value
£141k
Awarded value
£141k
Awarded 12 May 2025
Suppliers
1
Lots
1
1 awarded
Published
03 Sept 2025
Deadline 05 May 2025
Description
The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.
Scope
- Reference
- CF-3178200D0O000000rwimUAA
- Total value
- £140,671 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 11 May 2025 to 30 Mar 2026
- CPV classifications
- 85111810
- Particular suitability
- Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)
Submission & procedure
- Submission deadline
- 05 May 2025, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£141k
Award date
12 May 2025
Contract start
11 May 2025
Contract end
30 Mar 2026
Awarded to